Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Agex Therapeutics Inc
(NY:
AGE
)
0.6403
-0.0597 (-8.53%)
Streaming Delayed Price
Updated: 10:50 AM EDT, Aug 11, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
34,688
Open
0.7140
Bid (Size)
0.6400 (31)
Ask (Size)
0.6500 (122)
Prev. Close
0.7000
Today's Range
0.6403 - 0.7140
52wk Range
0.5162 - 1.390
Shares Outstanding
37,943,064
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday
July 06, 2022
Gainers Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday.
Via
Benzinga
Dr. Joanne Hackett Appointed Chairperson of AgeX Board of Directors
May 18, 2022
From
AgeX Therapeutics, Inc.
Via
Business Wire
Performance
YTD
-32.60%
-32.60%
1 Month
-1.51%
-1.51%
3 Month
-9.27%
-9.27%
6 Month
-21.46%
-21.46%
1 Year
-50.75%
-50.75%
More News
Read More
AgeX Therapeutics Reports First Quarter 2022 Financial Results
May 13, 2022
From
AgeX Therapeutics, Inc.
Via
Business Wire
60 Biggest Movers From Yesterday
April 26, 2022
Via
Benzinga
AgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results
March 29, 2022
From
AgeX Therapeutics, Inc.
Via
Business Wire
58 Biggest Movers From Yesterday
January 07, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 04, 2022
Via
InvestorPlace
61 Biggest Movers From Yesterday
January 04, 2022
Via
Benzinga
35 Stocks Moving In Monday's Mid-Day Session
January 03, 2022
Via
Benzinga
18 Stocks Moving in Monday's Pre-Market Session
January 03, 2022
Via
Benzinga
40 Biggest Movers From Friday
January 03, 2022
Via
Benzinga
Braeden Lichti: The Business of Anti-Aging and Rejuvenation Biotechnology
December 31, 2021
Via
PRLog
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
AgeX Therapeutics to Collaborate With University of California, Irvine, on Research Program for Exosome-Based Therapies for Certain Brain Disorders
December 14, 2021
From
AgeX Therapeutics, Inc.
Via
Business Wire
AgeX Therapeutics’ Licensee ImStem Biotechnology Announces First U.S. Multiple Sclerosis Patient Dosed with IMS001
November 30, 2021
From
AgeX Therapeutics, Inc.
Via
Business Wire
The Daily Biotech Pulse: Kura's Blood Cancer Drug Study Gets Partial Clinical Hold, Takeda FDA Nod, Puma Breast Cancer Treatment Gets Patent Extension
November 24, 2021
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
AgeX Therapeutics Receives Stock Exchange Deficiency Letter
November 23, 2021
From
AgeX Therapeutics , Inc.
Via
Business Wire
AgeX Therapeutics Reports Third Quarter 2021 Financial Results
November 12, 2021
From
AgeX Therapeutics, Inc.
Via
Business Wire
AgeX Therapeutics Reports Second Quarter 2021 Financial Results
August 13, 2021
From
AgeX Therapeutics, Inc.
Via
Business Wire
A Peek Into The Markets: US Stock Futures Down Following Friday's Rally
July 26, 2021
Via
Benzinga
5 Stocks To Watch For July 26, 2021
July 26, 2021
Via
Benzinga
AgeX Therapeutics and LyGenesis Terminate Merger Negotiations
July 23, 2021
From
AgeX Therapeutics, Inc.
Via
Business Wire
AgeX Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
May 17, 2021
From
AgeX Therapeutics
Via
Business Wire
58 Biggest Movers From Yesterday
April 27, 2021
Via
Benzinga
38 Stocks Moving In Monday's Mid-Day Session
April 26, 2021
Via
Benzinga
21 Stocks Moving in Monday's Pre-Market Session
April 26, 2021
Via
Benzinga
Exposures
COVID-19
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.